Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Ma

Showing results (901-910 of 918) with videos related to

Pageof 92
Sort By:
BMC Cancer|December 5, 2022
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trialYingjie Hu, Yingyan Han, Yuanming Shen, et al.
Frontiers of Medicine|November 24, 2022
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trialDanhui Weng, Huihua Xiong, Changkun Zhu, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Nature Communications|October 7, 2020
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19Yue Gao, Guang-Yao Cai, Wei Fang, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Oncotarget|March 26, 2016
Development and validation of a surgical-pathologic staging and scoring system for cervical cancerShuang Li, Xiong Li, Yuan Zhang, et al.
Cell Research|November 18, 2017
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemiaLiang Huang, Dan Liu, Na Wang, et al.
Nature Communications|October 10, 2022
Human papillomavirus integration perspective in small cell cervical carcinomaXiaoli Wang, Wenlong Jia, Mengyao Wang, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete ResectionHang Zhou, Xiong Li, Yuan Zhang, et al.
Pageof 92

Showing results (901-910 of 918) with videos related to

Sort By:
Pageof 92
BMC Cancer|December 5, 2022
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trialYingjie Hu, Yingyan Han, Yuanming Shen, et al.
Frontiers of Medicine|November 24, 2022
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trialDanhui Weng, Huihua Xiong, Changkun Zhu, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Nature Communications|October 7, 2020
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19Yue Gao, Guang-Yao Cai, Wei Fang, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Oncotarget|March 26, 2016
Development and validation of a surgical-pathologic staging and scoring system for cervical cancerShuang Li, Xiong Li, Yuan Zhang, et al.
Cell Research|November 18, 2017
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemiaLiang Huang, Dan Liu, Na Wang, et al.
Nature Communications|October 10, 2022
Human papillomavirus integration perspective in small cell cervical carcinomaXiaoli Wang, Wenlong Jia, Mengyao Wang, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete ResectionHang Zhou, Xiong Li, Yuan Zhang, et al.
Pageof 92